Advertisement
The neurostimulator, which sends electrical signals deep into his brain, has reduced Oran Knowlson’s daytime seizures by 80 per cent. The surgery was carried out in October as part of a trial at Great Ormond Street Hospital in London when Oran, who is now 13, was 12. The surgery was part of a trial in partnership with University College London, King’s College hospital and the University of Oxford.
His mother, Justine, told the BBC he was happier and had a “much better quality of life”.
“We’ve seen a big improvement, seizures have reduced and are less severe. He’s a lot more chatty, he’s more engaged. He’s turned 13 and I definitely now have a teenager – he’s happy to tell me no. But that adds to his quality of life, when he can express himself better,” she said.
Related Articles
Advertisement
The Picostim neurotransmitter is made by UK company Amber Therapeutics. It sits under the skull and sends electrical signals deep into the brain, reducing his daytime seizures The CADET pilot will now recruit three additional patients with Lennox-Gastaut syndrome, with a view to 22 patients being recruited to take part in a full trial.